Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 171. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_59	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	0.01 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_60	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	0.1 MOI	90% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_61	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	1 MOI	40% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_62	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	10 MOI	2% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_63	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.001 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_64	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.01 MOI	90% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_65	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.1 MOI	60% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_66	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	1 MOI	4% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_67	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	10 MOI	1% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_68	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.001 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_69	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.01 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_70	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.1 MOI	96% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_71	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	1 MOI	80% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_72	Adenovirus	Ad5WS1	DNA	Adenoviridae	E1B55K-deleted mutant driven by the E1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	10 MOI	20% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_73	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.01 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_74	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.1 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_75	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	1 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_76	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	10 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_77	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.01 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_78	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.1 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_79	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	1 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_80	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	10 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_81	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	0.01 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_82	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	0.1 MOI	85% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_83	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	1 MOI	35% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_84	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (YB-1 gene knockdown)	NA	NA	Crystal violet staining	10 MOI	1% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_85	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.001 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_86	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.01 MOI	90% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_87	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	0.1 MOI	20% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_88	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	1 MOI	2% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_89	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged YB-1 gene overexpressed)	NA	NA	Crystal violet staining	10 MOI	1% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_90	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.001 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_91	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.01 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_92	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	0.1 MOI	94% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_93	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	1 MOI	75% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_94	Adenovirus	Ad5GS3	DNA	Adenoviridae	E1B55K-deleted mutant driven by the MDR1 promoter	Yes	No	No	NA	Human breast cancer line	MCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)	NA	NA	Crystal violet staining	10 MOI	16% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26515462
OV_2222	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.01 MOI	100% cell survival after day 1	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2223	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.01 MOI	100% cell survival after day 2	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2224	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.01 MOI	70% cell survival after day 3	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2225	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.01 MOI	40% cell survival after day 4	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2226	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.01 MOI	20% cell death after day 5	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2227	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.1 MOI	90% cell survival after day 1	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2228	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.1 MOI	60% cell survival after day 2	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2229	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.1 MOI	30% cell survival after day 3	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2230	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.1 MOI	10% cell survival after day 4	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2231	Herpes simplex virus	HSV-1-G47-delta	DNA	Herpesviridae	Mutant for Gamma34.5, ICP6 and alpha47 gene	Yes	No	No	State key laboratory of oncology China	Human breast cancer cell line	MCF-7	1.0E+5 cells per well	NA	X-gal staining and MTT assay	0.1 MOI	100% cell death after day 5	No	No	NA	No response	NA	Caspase activation	NA	NA	22108767
OV_2634	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	Yes	No	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	90% cell survival after 3 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2635	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	Yes	No	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	60% cell survival after 6 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2640	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	60% cell survival after 3 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2641	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	30% cell survival after 6 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2642	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	60% cell survival after 3 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2643	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	20% cell survival after 6 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2654	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.001 MOI	80% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2655	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	80% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2656	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	60% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2657	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	50% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2658	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	10 MOI	30% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2659	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.001 MOI	70% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2660	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	70% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2661	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	30% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2662	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	20% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2663	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	10 MOI	10% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2806	Adenovirus	G47-delta	DNA	Adenoviridae	None	No	Virus strain in combination with palcitaxel (1.5 nm)	No	Sun-sen university cancer centre, china	Human breast cancer cell line	MCF-7	2000 cells per well	NA	Cell counting kit-8	0.25 MOI	50% cells viability	No	No	NA	No response	NA	Mitotic arrest and induction of apoptosis	NA	NA	23525624
OV_2807	Adenovirus	G47-delta	DNA	Adenoviridae	None	No	Virus strain in combination with palcitaxel (3 nm)	No	Sun-sen university cancer centre, china	Human breast cancer cell line	MCF-7	2000 cells per well	NA	Cell counting kit-8	0.5 MOI	40% cells are viable	No	No	NA	No response	NA	Mitotic arrest and induction of apoptosis	NA	NA	23525624
OV_2808	Adenovirus	G47-delta	DNA	Adenoviridae	None	No	Virus strain in combination with palcitaxel (4.5 nm)	No	Sun-sen university cancer centre, china	Human breast cancer cell line	MCF-7	2000 cells per well	NA	Cell counting kit-8	0.75 MOI	30% cells are viable	No	No	NA	No response	NA	Mitotic arrest and induction of apoptosis	NA	NA	23525624
OV_3006	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	100% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3007	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	90% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3008	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	80% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3009	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	3 MOI	75% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3010	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	10 MOI	20% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3011	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	100% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3012	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	75% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3013	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	50% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3014	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	3 MOI	30% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3015	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	10 MOI	5% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3016	Measles virus	wild type	RNA	Paramyxoviridae	None	No	CPT (10nM) drug administered first and then virus	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.20 fraction of cell affected, shows antagonism (CI = 1.34)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3017	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus added first and then drug CPT drug administered (10nM)	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.19 fraction of cell affected, shows antagonism (CI = 1.66)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3018	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus and drug (10nM) co-administered	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.56 fraction of cell affected, shows synergism (CI = 0.11)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3019	Measles virus	wild type	RNA	Paramyxoviridae	None	No	CPT (30nM) drug administered first and then virus	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.25 fraction of cell affected, shows antagonism (CI = 1.75)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3020	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus added first and then drug CPT drug administered (30nM)	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.19 fraction of cell affected, shows antagonism (CI = 2.02)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3021	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus and drug (30nM) co-administered	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.65 fraction of cell affected, shows synergism (CI = 0.21)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3022	Measles virus	wild type	RNA	Paramyxoviridae	None	No	CPT (50nM) drug administered first and then virus	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.37 fraction of cell affected, shows antagonism (CI = 1.2)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3023	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus added first and then drug CPT drug administered (50nM)	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.13 fraction of cell affected, shows antagonism (CI = 5.12)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3024	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus and drug (50nM) co-administered	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.69 fraction of cell affected, shows synergism (CI = 0.31)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3621	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	60% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3622	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	20% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3635	Mumps virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3636	Mumps virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3649	Measles and mumps virus	wild type	RNA	Paramyxoviridae	None	No	Measles virus in combination with mumps virus	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3650	Measles and mumps virus	wild type	RNA	Paramyxoviridae	None	No	Measles virus in combination with mumps virus	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	18% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3714	Enterovirus	ECHO-7 virus stain Rigvir	RNA	Picornaviridae	None	Yes	No	No	Public health england	Human breast cancer cell line	MCF-7	NA	NA	Live cell imaging system	1% virus concentration	27% cell viability	No	No	NA	No response	NA	NA	NA	NA	29581783
OV_3721	Enterovirus	ECHO-7 virus stain Rigvir	RNA	Picornaviridae	None	Yes	No	No	Public health england	Human breast cancer cell line	MCF-7	NA	NA	Live cell imaging system	10% virus concentration	24% cell viability	No	No	NA	No response	NA	NA	NA	NA	29581783
OV_3859	Newcastle disease virus	NDVstrain 320	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	67% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3860	Newcastle disease virus	NDVstrain 27	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	67% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3861	Newcastle disease virus	NDVstrain 852	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	67% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3862	Newcastle disease virus	NDVstrain AD	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	70% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3863	Newcastle disease virus	NDVstrain 860	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	72% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3864	Newcastle disease virus	NDVstrain 753	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	74% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3865	Newcastle disease virus	NDVstrain 429	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	75% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3866	Newcastle disease virus	NDVstrain 718	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	82% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3867	Newcastle disease virus	NDVstrain 770	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	84% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3868	Newcastle disease virus	NDVstrain 264	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	84% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3869	Newcastle disease virus	NDVstrain 777	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	84% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3870	Newcastle disease virus	NDVstrain 776	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	86% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3871	Newcastle disease virus	NDVstrain 922	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	86% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3872	Newcastle disease virus	NDVstrain 14	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	90% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3873	Newcastle disease virus	NDVstrain 49	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	90% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3874	Newcastle disease virus	NDVstrain 321	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	92% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3875	Newcastle disease virus	NDVstrain 945	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	94% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3876	Newcastle disease virus	NDVstrain 52	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	94% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3877	Newcastle disease virus	NDVstrain 48	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	94% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3878	Newcastle disease virus	NDVstrain 329	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	99% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3879	Newcastle disease virus	NDVstrain 746	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	99% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3880	Newcastle disease virus	NDVstrain 53	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3881	Newcastle disease virus	NDVstrain 389	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3882	Newcastle disease virus	NDVstrain 12	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3883	Newcastle disease virus	NDVstrain 373	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3884	Newcastle disease virus	NDVstrain 465	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3885	Newcastle disease virus	NDVstrain 769	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3886	Newcastle disease virus	NDVstrain 339	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4001	Newcastle disease virus	NDVwild 264	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	2 HAU	82% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4002	Newcastle disease virus	NDVwild 264	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	8 HAU	82% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4003	Newcastle disease virus	NDVwild 264	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	82% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4013	Newcastle disease virus	NDVwild 320	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	2 HAU	100% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4014	Newcastle disease virus	NDVwild 320	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	8 HAU	100% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4015	Newcastle disease virus	NDVwild 320	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	70% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4025	Newcastle disease virus	NDVwild 321	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	2 HAU	95% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4026	Newcastle disease virus	NDVwild 321	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	8 HAU	70% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4027	Newcastle disease virus	NDVwild 321	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	95% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4037	Newcastle disease virus	NDVwild 373	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	2 HAU	100% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4038	Newcastle disease virus	NDVwild 373	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	8 HAU	100% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4039	Newcastle disease virus	NDVwild 373	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	100% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4049	Newcastle disease virus	NDVwild 770	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	2 HAU	79% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4050	Newcastle disease virus	NDVwild 770	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	8 HAU	80% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4051	Newcastle disease virus	NDVwild 770	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	80% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4061	Newcastle disease virus	NDVwild 852	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	2 HAU	62% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4062	Newcastle disease virus	NDVwild 852	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	8 HAU	62% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4063	Newcastle disease virus	NDVwild 852	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	62% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4073	Newcastle disease virus	NDVwild 776	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	2 HAU	90% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4074	Newcastle disease virus	NDVwild 776	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	8 HAU	90% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4075	Newcastle disease virus	NDVwild 776	RNA	Paramyxoviridae	None	Yes	No	No	Russian academy of science, Russia	Human breast cancer adenocarcinoma cell line	MCF-7	10000 cells per well	NA	MTT assay	16 HAU	80% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_4081	Adenovirus	Adenovirus ZD55	DNA	Adenoviridae	Virus encoded with drosophila dNK gene	No	Virus in combination with drug BVDU(10mg/kg)	No	Shanghai cell collection	Human breast cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	Significant reduction in cell growth	No	No	NA	No response	NA	Virus induced apoptosis in cancer cell	NA	NA	26203222
OV_4082	Adenovirus	Adenovirus ZD55	DNA	Adenoviridae	Virus encoded with drosophila dNK gene	No	Virus in combination with drug DFDC(10mg/kg)	No	Shanghai cell collection	Human breast cell line	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	Significant reduction in cell growth	No	No	NA	No response	NA	Virus induced apoptosis in cancer cell	NA	NA	26203222
OV_4150	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4151	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	60% cell viability after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4152	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	60% cell viability after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4153	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	25% cell viability after 6 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4154	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	10% cell viability after 7 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4155	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4156	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	40% cell viability after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4157	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	30% cell viability after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4158	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	10% cell viability after 6 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4159	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell killing after 7 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4160	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4161	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	60% cell viability after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4162	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	50% cell viability after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4163	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	5% cell viability after 6 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4164	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	100% cell killing after 7 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4165	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 48 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4166	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 48 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	20% cell viability after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4167	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 48 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	15% cell viability after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4168	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 48 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	2% cell viability after 6 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4169	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 48 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell killing after 7 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4324	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human breast adenocarcinoma	MCF-7	4000 cells per well	NA	MTT assay	10 pfu	95.2 % cell viability after 72 hours	No	No	NA	No response	NA	Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	NA	NA	26373347
OV_4428	Vesicular stomatitis virus	RdB	RNA	Rhabdoviridae	Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	1.2E+4 cells per well	NA	MTT assay	21:1 particle to pfu	48% cell survival after 4 days	No	No	NA	No response	NA	NA	NA	NA	26430798
OV_4436	Vesicular stomatitis virus	RdB-1L-VSVG	RNA	Rhabdoviridae	Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	1.2E+4 cells per well	NA	MTT assay	24:1 particle to pfu	1% cell survival after 4 days	No	No	NA	No response	NA	NA	NA	NA	26430798
OV_4477	Adenovirus	oAD/DCN-shMet	DNA	Adenoviridae	Adenovirus conjugated with DCN and shMet	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	70% confluence in 24 well plate	NA	MTT assay	100 MOI	88% cancer cell survivalability after 48 hours	No	No	NA	No response	NA	NA	Increased in IL-6 level to 140pg/ml compared to control 20 pg/ml	NA	26951927
OV_4478	Adenovirus	oAD/DCN-shMet/PP	DNA	Adenoviridae	Adenovirus conjugated with DCN, shMet and PEGylated at PAMAM	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	70% confluence in 24 well plate	NA	MTT assay	100 MOI	85% cancer cell survivalability after 48 hours	No	No	NA	No response	NA	NA	Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml	NA	26951927
OV_4479	Adenovirus	oAD/DCN-shMet/PPE	DNA	Adenoviridae	Adenovirus conjugated with DCN, shMet and Erbitux-conjugated PEGylated at PAMAM	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	70% confluence in 24 well plate	NA	MTT assay	100 MOI	82% cancer cell survivalability after 48 hours	No	No	NA	No response	NA	NA	Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml	NA	26951927
OV_5344	Newcastle disease virus	LaSota	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human mammary gland adenocarcinoma	MCF-7	5.0E+4 cells per well	NA	MTT assay	0.001 MOI	44% cells remain viable after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis	Induced production of IFN-alpha, IFN-beta, IL-6and IFN-gamma	NA	28293547
OV_5552	Reovirus	Reovirus serotype 3	RNA	Reoviridae	None	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	60% confluency	NA	NA	40 MOI	Cell viability drops from 93 to 16% after 72 hours	No	No	NA	No response	NA	Induction of apoptosis by virus infection	NA	NA	US6994858